Repurposing the diuretic benzamil as an anti-osteosarcoma agent that acts by suppressing integrin/FAK/STAT3 signalling and compromising mitochondrial function
Article in Bone and Joint Research (April 2024)
The most recent citing publications are shown below. View all 380 publications that cite this research output on Dimensions.
Article in Bone and Joint Research (April 2024)
Article in BMC Cancer (March 2024)
Article in Cureus (March 2024)